Renaissance Technologies
PMD

Renaissance Technologies’s Psychemedics Corporation PMD Stock Holding History

Renaissance Technologies’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-270,863
Closed -$626K – 3999
2024
Q3 		$626K Buy
270,863
+13,900
+5% +$31.2K ﹤0.01% 2684
2024
Q2 		$622K Sell
256,963
-2,900
-1% -$7.37K ﹤0.01% 2596
2024
Q1 		$761K Sell
259,863
-5,700
-2% -$18.1K ﹤0.01% 2657
2023
Q4 		$786K Sell
265,563
-8,100
-3% -$21.6K ﹤0.01% 2550
2023
Q3 		$1.09M Sell
273,663
-4,300
-2% -$19.2K ﹤0.01% 2240
2023
Q2 		$1.27M Sell
277,963
-3,300
-1% -$16.7K ﹤0.01% 2319
2023
Q1 		$1.48M Sell
281,263
-9,200
-3% -$51K ﹤0.01% 2214
2022
Q4 		$1.43M Sell
290,463
-15,700
-5% -$92.6K ﹤0.01% 2297
2022
Q3 		$1.98M Sell
306,163
-20,004
-6% -$129K ﹤0.01% 2016
2022
Q2 		$2.07M Sell
326,167
-15,255
-4% -$97.7K ﹤0.01% 2161
2022
Q1 		$2.36M Sell
341,422
-30,724
-8% -$217K ﹤0.01% 2118
2021
Q4 		$2.61M Sell
372,146
-1,294
-0.3% -$10.3K ﹤0.01% 1945
2021
Q3 		$3.14M Sell
373,440
-10,900
-3% -$79.8K ﹤0.01% 1750
2021
Q2 		$2.67M Sell
384,340
-29,320
-7% -$205K ﹤0.01% 2051
2021
Q1 		$2.56M Sell
413,660
-40,980
-9% -$272K ﹤0.01% 2060
2020
Q4 		$2.31M Sell
454,640
-100
-0% -$434 ﹤0.01% 2039
2020
Q3 		$2M Sell
454,740
-13,714
-3% -$66.8K ﹤0.01% 2131
2020
Q2 		$2.6M Buy
468,454
+24,816
+6% +$139K ﹤0.01% 2025
2020
Q1 		$2.68M Sell
443,638
-31,539
-7% -$266K ﹤0.01% 1900
2019
Q4 		$4.35M Buy
475,177
+22,311
+5% +$206K ﹤0.01% 1941
2019
Q3 		$4.13M Buy
452,866
+31,095
+7% +$264K ﹤0.01% 1900
2019
Q2 		$4.26M Buy
421,771
+2,634
+0.6% +$29.9K ﹤0.01% 1902
2019
Q1 		$5.88M Sell
419,137
-19,863
-5% -$341K 0.01% 1700
2018
Q4 		$6.97M Sell
439,000
-29,066
-6% -$501K 0.01% 1530
2018
Q3 		$8.8M Buy
468,066
+18,366
+4% +$366K 0.01% 1441
2018
Q2 		$8.65M Sell
449,700
-100
-0% -$2.03K 0.01% 1449
2018
Q1 		$9.61M Sell
449,800
-14,629
-3% -$304K 0.01% 1393
2017
Q4 		$9.55M Sell
464,429
-26,571
-5% -$493K 0.01% 1419
2017
Q3 		$9.05M Buy
491,000
+34,500
+8% +$759K 0.01% 1396
2017
Q2 		$11.4M Sell
456,500
-10,900
-2% -$229K 0.01% 1200
2017
Q1 		$9.37M Sell
467,400
-32,590
-7% -$715K 0.01% 1289
2016
Q4 		$12.3M Buy
499,990
+65,290
+15% +$1.46M 0.02% 1086
2016
Q3 		$8.62M Buy
434,700
+27,600
+7% +$512K 0.02% 1240
2016
Q2 		$5.59M Sell
407,100
-3,300
-0.8% -$45.9K 0.01% 1540
2016
Q1 		$5.64M Sell
410,400
-25,500
-6% -$292K 0.01% 1532
2015
Q4 		$4.42M Sell
435,900
-6,169
-1% -$67.2K 0.01% 1572
2015
Q3 		$4.44M Buy
442,069
+11,369
+3% +$132K 0.01% 1474
2015
Q2 		$6.39M Buy
430,700
+400
+0.1% +$6.23K 0.01% 1282
2015
Q1 		$7.14M Sell
430,300
-4,600
-1% -$71.8K 0.02% 1145
2014
Q4 		$6.59M Sell
434,900
-300
-0.1% -$4.36K 0.02% 1115
2014
Q3 		$6.16M Sell
435,200
-4,400
-1% -$62.5K 0.02% 1053
2014
Q2 		$6.22M Buy
439,600
+17,500
+4% +$266K 0.01% 1100
2014
Q1 		$7.23M Buy
422,100
+18,900
+5% +$313K 0.02% 1051
2013
Q4 		$5.92M Buy
403,200
+29,200
+8% +$402K 0.01% 1094
2013
Q3 		$4.96M Buy
374,000
+30,500
+9% +$379K 0.01% 1167
2013
Q2 		$3.69M Buy
+343,500
New +$3.86M 0.01% 1267

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
SMP
Santa Monica Partners Palm Beach Gardens, Florida $179M AUM 19.18% 1-Year Est. Return

Renaissance Technologies's PMD Position: Q4 2024 in Review

Renaissance Technologies sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 270,863 shares — an estimated $626K sold.

Renaissance Technologies first reported a position in PMD in Q2 2013 and held it in 46 quarters. The position peaked at $12.3M in Q4 2016. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.

  • Renaissance Technologies reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 270,863 Psychemedics Corporation shares in Q4 2024, an estimated $626K.
  • Renaissance Technologies first reported a position in Psychemedics Corporation in Q2 2013 and held it in 46 quarters.
  • Renaissance Technologies's Psychemedics Corporation position peaked at $12.3M in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.